BNC Korea Co., Ltd.
KOE: 256840.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Wan-Gyu Choi
- Employees
- 213
- Headquarters
- Daegu, South Korea
- IPO year
- 2019
- Market cap
- ₩257.5B
- Website
- https://www.bnckorea.co.kr
Loading 256840…
Loading profile data…Frequently asked questions about 256840
What does BNC Korea Co., Ltd. (256840.KQ) do?
BNC Korea Co., Ltd. engages in the research and development, production, and sale of biomaterials in South Korea. The company offers HA fillers and skin booster fillers, including Cutegel, Cutegel Lidocaine, FLORE Lidocaine, ChungA-an, CUTEGEL-M, Cutegel Hydro, S-DNA, and H-DNA, which are used to temporarily reduce facial wrinkles through physic...
Where does 256840.KQ trade?
BNC Korea Co., Ltd. (256840.KQ) trades on the KOSDAQ.
What sector is 256840.KQ in?
BNC Korea Co., Ltd. (256840.KQ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of BNC Korea Co., Ltd.?
Wan-Gyu Choi is the chief executive officer of BNC Korea Co., Ltd. (256840.KQ).
Where is BNC Korea Co., Ltd. headquartered?
BNC Korea Co., Ltd. is headquartered in South Korea.
Does 256840.KQ pay a dividend?
Yes — BNC Korea Co., Ltd. (256840.KQ) paid a trailing twelve-month dividend of KRW 70.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 256840.KQ go public?
BNC Korea Co., Ltd. (256840.KQ) completed its initial public offering in 2019.